Article
Emerging therapies for hepatitis C virus.
Expert opinion on emerging drugs - 1 Dec 2010
Birerdinc Aybike, Younossi Zobair M
Abstract excerpt
IMPORTANCE OF THE FIELD: Currently, 170 million people worldwide are affected by the HCV. Chronic HCV infection is amongst the leading causes of chronic liver disease and its complications such as cirrhosis and hepatocellular carcinoma, making it the most common reason for liver transplantation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
